Effect of an educational intervention based on the theory of planned behavior on improving medication adherence in patients with multiple sclerosis treated with injectable disease-modifying drugs: randomized controlled trial

[1] Ben-Zacharia A(2018)Impact of shared decision making on multiple sclerosis Int J MS Care 6 287-297

[2] Adamson M(2014)The study of reliability of performance assessment of self-care skills (PASS) in evaluating the self-care skills of adult patients suffering from Multiple Sclerosis in Tehran Journal Rehabilitation 15 64-70

[3] Boyd A(2020)Advances in oral immunomodulating therapies in relapsing multiple sclerosis Lancet Neurol 19 336-347

[4] Azadi H(2020)Interferons in the Treatment of Multiple Sclerosis: A Clinical Efficacy, Safety, and Tolerability Update International journal of MS care 22 165-172

[5] Tahmasbi A(2018)Adherence to disease-modifying therapies in patients with multiple sclerosis Patient Prefer Adherence 12 1557-1566

[6] Derfuss T(2012)Systematic review of disease-modifying therapies to assess unmet needs in multiple sclerosis: tolerability and adherence Mult Scler 18 932-946

[7] Mehling M(2013)Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis J Manag Care Pharm 19 S24-S40

[8] Papadopoulou A(2018)Factors affecting the adherence to disease-modifying therapy in patients with multiple sclerosis J Neurosci Nurs 50 291-297

[9] Bar-Or A(2010)Enhancing adherence through education J Neurosci Nurs 42 19-29

[10] Cohen JA(2017)Predicting factors affecting medication adherence and physical activity in patients with type-2 diabetes mellitus based on the theory of planned behavior Journal of School of Public Health and Institute of Public Health Research 15 133-146

[1] Ben-Zacharia A(2018)Impact of shared decision making on multiple sclerosis Int J MS Care 6 287-297

[2] Adamson M(2014)The study of reliability of performance assessment of self-care skills (PASS) in evaluating the self-care skills of adult patients suffering from Multiple Sclerosis in Tehran Journal Rehabilitation 15 64-70

[3] Boyd A(2020)Advances in oral immunomodulating therapies in relapsing multiple sclerosis Lancet Neurol 19 336-347

[4] Azadi H(2020)Interferons in the Treatment of Multiple Sclerosis: A Clinical Efficacy, Safety, and Tolerability Update International journal of MS care 22 165-172

[5] Tahmasbi A(2018)Adherence to disease-modifying therapies in patients with multiple sclerosis Patient Prefer Adherence 12 1557-1566

[6] Derfuss T(2012)Systematic review of disease-modifying therapies to assess unmet needs in multiple sclerosis: tolerability and adherence Mult Scler 18 932-946

[7] Mehling M(2013)Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis J Manag Care Pharm 19 S24-S40

[8] Papadopoulou A(2018)Factors affecting the adherence to disease-modifying therapy in patients with multiple sclerosis J Neurosci Nurs 50 291-297

[9] Bar-Or A(2010)Enhancing adherence through education J Neurosci Nurs 42 19-29

[10] Cohen JA(2017)Predicting factors affecting medication adherence and physical activity in patients with type-2 diabetes mellitus based on the theory of planned behavior Journal of School of Public Health and Institute of Public Health Research 15 133-146